Remicade and Vasculitis cerebral - a phase IV clinical study of FDA data

Summary:

Vasculitis cerebral is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Prednisone, and have Polyarthritis.

The phase IV clinical study analyzes which people have Vasculitis cerebral when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Vasculitis cerebral?

Vasculitis cerebral (inflammation of the blood vessel wall involving the brain and occasionally the spinal cord) is found to be associated with 66 drugs and 286 conditions by eHealthMe. Check the latest studies of Vasculitis cerebral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 31 people (0.01%) have Vasculitis cerebral.

Could Remicade cause Vasculitis cerebral?

Among these 31 people:

How long have people been on Remicade when they have Vasculitis cerebral? *

What is the gender of people who have Vasculitis cerebral when taking Remicade? *

female: 70.97 %
male: 29.03 %

What is the age of people who have Vasculitis cerebral when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Vasculitis cerebral? *

Consciousness - Decreased: 10 people, 32.26%
Bradycardia (abnormally slow heart action): 6 people, 19.35%
Pneumonia: 5 people, 16.13%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 16.13%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 16.13%
Enterococcal Sepsis: 5 people, 16.13%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 4 people, 12.90%
Brain Damage: 4 people, 12.90%
Multi-Organ Failure (multisystem organ failure): 4 people, 12.90%
Heart Disease: 4 people, 12.90%

What are the existing conditions these people have? *

Polyarthritis (arthritis which involves 5 or more joints simultaneously): 6 people, 19.35%
High Blood Pressure: 2 people, 6.45%
Viral Infection: 1 person, 3.23%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 3.23%
Gastritis (inflammation of stomach): 1 person, 3.23%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Vasculitis cerebral?

- Check whether Vasculitis cerebral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasculitis cerebral:

Vasculitis cerebral (66 drugs)

Browse all the conditions that are associated with Vasculitis cerebral:

Vasculitis cerebral (286 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.